Who Optimizes SG&A Costs Better? Walgreens Boots Alliance, Inc. or MorphoSys AG

Optimizing SG&A Costs: A Tale of Two Companies

In the competitive world of business, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Walgreens Boots Alliance, Inc. and MorphoSys AG, two giants in their respective fields, offer a fascinating study in cost optimization from 2014 to 2023.

Walgreens Boots Alliance, a leader in the retail pharmacy sector, consistently maintained high SG&A expenses, peaking at approximately $25.5 billion in 2023. This reflects a steady increase of around 44% over the decade, highlighting their expansive operational scale. In contrast, MorphoSys AG, a biotechnology firm, exhibited a more volatile SG&A trend, with expenses surging by over 900% from 2014 to 2021, before stabilizing around $92 million in 2023.

This comparison underscores the diverse strategies employed by companies in different industries to manage operational costs, with Walgreens focusing on scale and MorphoSys on strategic growth.